Altamira Therapeutics Says Positive Outlook For 2023, And Our Transformation Into A Pureplay RNA Therapeutics Company, Remains Unchanged Even Though Our Timeline Has Shifted Into The New Year
"Our positive outlook for 2023, and our transformation into a pureplay RNA therapeutics company, remains unchanged even though our timeline has shifted into the new year," said Thomas Meyer, Altamira's founder, Chairman and CEO.